Moi Corporation
Financial Summary
For the second quarter of the FY2027, net sales were 1,573 million yen (YoY -7.3%), actual gross profit was 506 million yen (YoY +7.3%), achieving the highest ever pro forma margin. Operating income 60 million yen, ordinary income 181 million yen, net income attributable to owners of the parent 121 million yen. For FY2027 full-year, guidance is net sales 6,829 million yen, operating income 409 million yen, ordinary income 461 million yen. However, net income remains undetermined due to estimated recoverability of deferred tax assets.
Key Figures
- Net sales: 1,573 million yen（YoY -7.3%）
- Actual gross profit: 506 million yen（YoY +7.3%）
- Operating income: 60 million yen（YoY -36.0%）
- Ordinary income: 181 million yen
- Net income attributable to owners of the parent: 121 million yen（YoY +76.6%）
AI要約
Section heading
FY2027 first half results for the period ending January 2027: net sales of 1,573 million yen YoY down 7.3%, actual gross profit of 506 million yen, exceeding the prior year. Although growth in key product sales and reduced settlement fees weigh on profits, membership sales and improved gross margin contribute to earnings. Full-year guidance is net sales 6,829 million yen, operating income 409 million yen, and ordinary income 461 million yen, with a plan to continue investments in line with growth strategy.
Second section heading
In the explanation to shareholders and investors (Q&A), we describe the attribution of rights to jointly filed patents and potential monetization in medical and drug discovery areas, regulatory and ethical risks, and the impact of future commercialization timing and R&D costs. As risk management, we highlight reducing dependence on third parties and strengthening our own infrastructure, and present mid- to long-term growth strategy including AI-enabled live streaming.
Net sales Trend
Actual gross profit margin
Moi Corporation
Company overview · Stock price · Financial data · All IR
